|
|
$894 million deal ends pain of Pfizer's lawsuits
TRENTON, N.J. - Drug giant Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits.
Nations:U.S. Activities:U.S. Painkiller Crisis Source:(AP)
2008-10-17
Court limits Merck monitoring in Vioxx case
Drugmaker Merck & Co. is not liable for the medical monitoring of Vioxx users not claiming injury, the New Jersey Supreme Court ruled Wednesday.
Activities:U.S. Painkiller Crisis
2008-06-05
NJ, Texas courts scrap awards from Vioxx cases
Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drugmaker Merck & Co. Inc. stemming from some of the earliest trials involving its once popular painkiller Vioxx.
Activities:U.S. Painkiller Crisis
2008-05-29
Merck agrees to $58M settlement over Vioxx ad claims
Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks.
Nations:U.S. Activities:U.S. Painkiller Crisis
2008-05-20
Pfizer reaches deal with some Celebrex users: report
Pfizer Inc has reached tentative deals with some patients who claim to have suffered heart attacks and strokes from taking the company's Celebrex and Bextra pain medicines, the Wall Street Journal said on Friday, citing plaintiff attorneys.
Activities:U.S. Painkiller Crisis
2008-05-02
| Headlines |
|
Matches Shown: | 1-50 | 51-100
|
|
|